Isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2/STAT3 pathway in streptozotocin-induced diabetic rats

The aim of the current study was to evaluate the protective effects and mechanisms of isoliquiritigenin (ISO) on acute renal injury. CCK-8 assays were applied to assess the effects of ISO at different doses (20, 40, and 80 μg/mL) on oxidative damage in human renal HK-2 cells incubated with high gluc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leiming Sun, Zheng Yang, Jiaying Zhang, Jie Wang
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/980eb883e6384058b018ed173c5166b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:980eb883e6384058b018ed173c5166b1
record_format dspace
spelling oai:doaj.org-article:980eb883e6384058b018ed173c5166b12021-12-01T14:41:00ZIsoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2/STAT3 pathway in streptozotocin-induced diabetic rats2165-59792165-598710.1080/21655979.2021.2006978https://doaj.org/article/980eb883e6384058b018ed173c5166b12021-12-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.2006978https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987The aim of the current study was to evaluate the protective effects and mechanisms of isoliquiritigenin (ISO) on acute renal injury. CCK-8 assays were applied to assess the effects of ISO at different doses (20, 40, and 80 μg/mL) on oxidative damage in human renal HK-2 cells incubated with high glucose. After the diabetic nephropathy (DN) rat model was established, the model animals were randomly assigned to saline-treated control, three model groups received the 10, 20 and 40 mg/kg ISO, respectively, using the healthy Sprague-Dawley (SD) rats as normal control. The blood biochemical indexes, renal functions, oxidative stress, morphological changes, fibrosis- and JAK2/STAT3-related factors in DN model rats were all assessed. The cellular viability of the renal HK-2 cells with oxidative damages were all markedly ameliorated via the incubation of ISO between 10 and 80 μg/mL compared with negative control. In addition, the significantly down-regulated ROS content and up-regulated expression levels of GSH, SOD2, and GPX1 were all observed in ISO-treated groups. Long-term administration of ISO at different doses in DN rats effectively improved general diabetic characteristics and renal morphology. Furthermore, long-term administration of ISO could ameliorate excessive oxidation stress, down-regulate the expression levels of renal fibrosis- and inflammation-related factors, as well as inhibit the JAK2/STAT3 signaling pathway. In conclusion, ISO at all three dosages could efficiently improve the renal injury induced by STZ via ameliorating renal fibrosis, oxidative stress, and inhibiting JAK2/STAT3 signaling pathways in the DN rats.Leiming SunZheng YangJiaying ZhangJie WangTaylor & Francis Grouparticleisoliquiritigenindiabetic nephropathyoxidative damagefibrosistgf-β/smad signaling pathwayBiotechnologyTP248.13-248.65ENBioengineered, Vol 12, Iss 2, Pp 11188-11200 (2021)
institution DOAJ
collection DOAJ
language EN
topic isoliquiritigenin
diabetic nephropathy
oxidative damage
fibrosis
tgf-β/smad signaling pathway
Biotechnology
TP248.13-248.65
spellingShingle isoliquiritigenin
diabetic nephropathy
oxidative damage
fibrosis
tgf-β/smad signaling pathway
Biotechnology
TP248.13-248.65
Leiming Sun
Zheng Yang
Jiaying Zhang
Jie Wang
Isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2/STAT3 pathway in streptozotocin-induced diabetic rats
description The aim of the current study was to evaluate the protective effects and mechanisms of isoliquiritigenin (ISO) on acute renal injury. CCK-8 assays were applied to assess the effects of ISO at different doses (20, 40, and 80 μg/mL) on oxidative damage in human renal HK-2 cells incubated with high glucose. After the diabetic nephropathy (DN) rat model was established, the model animals were randomly assigned to saline-treated control, three model groups received the 10, 20 and 40 mg/kg ISO, respectively, using the healthy Sprague-Dawley (SD) rats as normal control. The blood biochemical indexes, renal functions, oxidative stress, morphological changes, fibrosis- and JAK2/STAT3-related factors in DN model rats were all assessed. The cellular viability of the renal HK-2 cells with oxidative damages were all markedly ameliorated via the incubation of ISO between 10 and 80 μg/mL compared with negative control. In addition, the significantly down-regulated ROS content and up-regulated expression levels of GSH, SOD2, and GPX1 were all observed in ISO-treated groups. Long-term administration of ISO at different doses in DN rats effectively improved general diabetic characteristics and renal morphology. Furthermore, long-term administration of ISO could ameliorate excessive oxidation stress, down-regulate the expression levels of renal fibrosis- and inflammation-related factors, as well as inhibit the JAK2/STAT3 signaling pathway. In conclusion, ISO at all three dosages could efficiently improve the renal injury induced by STZ via ameliorating renal fibrosis, oxidative stress, and inhibiting JAK2/STAT3 signaling pathways in the DN rats.
format article
author Leiming Sun
Zheng Yang
Jiaying Zhang
Jie Wang
author_facet Leiming Sun
Zheng Yang
Jiaying Zhang
Jie Wang
author_sort Leiming Sun
title Isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2/STAT3 pathway in streptozotocin-induced diabetic rats
title_short Isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2/STAT3 pathway in streptozotocin-induced diabetic rats
title_full Isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2/STAT3 pathway in streptozotocin-induced diabetic rats
title_fullStr Isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2/STAT3 pathway in streptozotocin-induced diabetic rats
title_full_unstemmed Isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and JAK2/STAT3 pathway in streptozotocin-induced diabetic rats
title_sort isoliquiritigenin attenuates acute renal injury through suppressing oxidative stress, fibrosis and jak2/stat3 pathway in streptozotocin-induced diabetic rats
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/980eb883e6384058b018ed173c5166b1
work_keys_str_mv AT leimingsun isoliquiritigeninattenuatesacuterenalinjurythroughsuppressingoxidativestressfibrosisandjak2stat3pathwayinstreptozotocininduceddiabeticrats
AT zhengyang isoliquiritigeninattenuatesacuterenalinjurythroughsuppressingoxidativestressfibrosisandjak2stat3pathwayinstreptozotocininduceddiabeticrats
AT jiayingzhang isoliquiritigeninattenuatesacuterenalinjurythroughsuppressingoxidativestressfibrosisandjak2stat3pathwayinstreptozotocininduceddiabeticrats
AT jiewang isoliquiritigeninattenuatesacuterenalinjurythroughsuppressingoxidativestressfibrosisandjak2stat3pathwayinstreptozotocininduceddiabeticrats
_version_ 1718405009603821568